Monoclonal antibody levels and protection from COVID-19

Multiple monoclonal antibodies have been shown to be effective for both prophylaxis and therapy for SARS-CoV-2 infection. Here we aggregate data from randomized controlled trials assessing the use of monoclonal antibodies (mAb) in preventing symptomatic SARS-CoV-2 infection. We use data on the in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stadler, Eva, Burgess, Martin T., Schlub, Timothy E., Khan, Shanchita R., Chai, Khai Li, McQuilten, Zoe K., Wood, Erica M., Polizzotto, Mark N., Kent, Stephen J., Cromer, Deborah, Davenport, Miles P., Khoury, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382502/
https://www.ncbi.nlm.nih.gov/pubmed/37507368
http://dx.doi.org/10.1038/s41467-023-40204-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382502/
https://www.ncbi.nlm.nih.gov/pubmed/37507368
http://dx.doi.org/10.1038/s41467-023-40204-1

Ejemplares similares